(Q52000664)

19 April 2018

title

Comorbidity of drug dependence and other mental disorders: a two-phase study of prevalence at outpatient treatment centres in Italy. (English)

1 reference

19 April 2018

0 references

1 reference

1 reference

1 reference

Pozzi G

1

1 reference

19 April 2018

Bacigalupi M

series ordinal

2

1 reference

19 April 2018

Tempesta E

series ordinal

3

1 reference

19 April 2018

publication date

1 June 1997

1 reference

19 April 2018

Drug and Alcohol Dependence

published in

1 reference

19 April 2018

volume

46

1 reference

19 April 2018

issue

1-2

1 reference

19 April 2018

page(s)

69-77

1 reference

19 April 2018

Reliability of dual diagnosis. Substance dependence and psychiatric disorders

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2897%2900042-2

7 January 2021

Substance abuse and psychopathology. A diagnostic screening of Italian narcotic addicts

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2897%2900042-2

7 January 2021

Substance abuse and mental disorders: the dual diagnoses concept

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2897%2900042-2

7 January 2021

Substance abuse/mental illness: diagnostic issues.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2897%2900042-2

7 January 2021

Substance abuse disorders: a psychiatric priority. Group for the Advancement of Psychiatry Committee on Alcoholism and the Addictions

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2897%2900042-2

7 January 2021

Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2897%2900042-2

7 January 2021

DSM-III psychiatric diagnosis of narcotic addicts. Recent findings.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2897%2900042-2

7 January 2021

An improved diagnostic evaluation instrument for substance abuse patients. The Addiction Severity Index.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2897%2900042-2

7 January 2021

Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2897%2900042-2

7 January 2021

The Composite International Diagnostic Interview. An epidemiologic Instrument suitable for use in conjunction with different diagnostic systems and in different cultures

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2897%2900042-2

7 January 2021

The prevalence of psychiatric disorders in patients with alcohol and other drug problems

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2897%2900042-2

7 January 2021

Heterogeneity of psychiatric diagnosis in treated opiate addicts.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2897%2900042-2

7 January 2021

Prevalence and correlates of drug use and dependence in the United States. Results from the National Comorbidity Survey

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2897%2900042-2

7 January 2021

Methodological considerations in the diagnosis of coexisting psychiatric disorders in substance abusers

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2897%2900042-2

7 January 2021

Research on psychopathology and addiction: treatment implications

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2897%2900042-2

7 January 2021

Psychiatric disorders in a Dutch addict population: rates and correlates of DSM-III diagnosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2897%2900042-2

7 January 2021

Comorbidity and treatment planning: summary and future directions

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2897%2900042-2

7 January 2021

10.1016/S0376-8716(97)00042-2

Identifiers

DOI

1 reference

19 April 2018

1 reference

19 April 2018